Email ID
Password
Sign me in automatically next time
Scrip Regulatory Affairs
Heated calls for WHO to drop controversial anti-counterfeiting initiative
21 May 2010
Elizabeth Sukkar, Anju Ghangurde

There is a heated debate going on over what role the World Health Organization should have with the controversial International Medical Products Anti-Counterfeiting Taskforce that it is hosting. Non-governmental organisations want the WHO to disengage to safeguard its credibility, but the pharmaceutical industry believes that it has a key role to play...

Please login to read the full article.
 
 
 
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
   
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36